Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

9 Jan 2015 07:00

RNS Number : 7095B
MJ Gleeson PLC
09 January 2015
 



MJ GLEESON PLC

('Gleeson' or 'the Group')

TRADING UPDATE

 

MJ Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, today issues the following trading update ahead of its interim results for the six months ended 31 December 2014, which will be announced on Wednesday 25th February 2015.

 

The Group continues to trade well and expects profits for H1 2015 to show a strong increase over H1 2014.

 

Gleeson Homes

 

Market conditions remain healthy, with strong customer demand in all of our regions.

 

We continued to make strong progress in the period, selling 321 homes, an increase of 24% on the previous year's total of 258.

 

The current forward order book of 299 units is an increase of 23% over the previous year's figure of 240 and, as previously announced, the Board expects to record an increase in completions in the year to 30 June 2015 of not less than 25% against the prior year total of 561 units.

 

The business currently has 39 active sites, compared with 33 in the corresponding period.

 

The land pipeline of owned and conditionally purchased plots at 31 December 2014 increased by 30% compared to the prior year, totalling 5,267 plots, of which 1,588 plots have been purchased subject to planning permission. In addition, there are a further 1,900 plots which are in the pipeline to be acquired.

 

Gleeson Strategic Land

 

During the period we sold a 15 acre site with planning permission for 51 plots, along with the sale of 1.5 acres of commercial land from our site in Thanet, Kent.

 

There are currently eight sites in the portfolio with planning permission or a resolution to grant permission. Six of these sites, which will deliver 672 plots, are being progressed for sale in the current financial year.

 

In addition, there are 13 sites where the business is currently awaiting either the determination of a planning application or the outcome of a planning appeal. It may also be possible to sell a number of these sites in the current financial year.

 

Jolyon Harrison, Chief Executive, commented:

 

"The first half performance of both Gleeson Homes and Gleeson Strategic Land has been encouraging as we continue to benefit from our focussed, twin track strategy of providing low cost family homes in the North of England, and strategic land promotion in the South. We expect to report a result for the full year in line with current expectations."

 

9 January 2015

 

 

 

 

Enquiries:

 

MJ Gleeson plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Helen Tarbet

Mark Garraway

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

 

 

Notes to Editors

 

MJ Gleeson plc operates in the house building sector through the following business units: Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUMCGUPAGQR
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.